Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients
Open Access
- 29 April 2014
- journal article
- Published by Informa UK Limited in Autophagy
- Vol. 10 (7), 1167-1178
- https://doi.org/10.4161/auto.28678
Abstract
Recent in vitro studies have suggested that autophagy may play a role in both HIV-1 replication and disease progression. In this study we investigated whether autophagy protects the small proportion of HIV-1 infected individuals who remain clinically stable for years in the absence of antiretroviral therapy, these named long-term nonprogressors (LTNP) and elite controllers (EC). We found that peripheral blood mononuclear cells (PBMC) of the HIV-1 controllers present a significantly higher amount of autophagic vesicles associated with an increased expression of autophagic markers with respect to normal progressors. Of note, ex vivo treatment of PBMC from the HIV-1 controllers with the MTOR inhibitor rapamycin results in a more efficient autophagic response, leading to a reduced viral production. These data lead us to propose that autophagy contributes to limiting viral pathogenesis in HIV-1 controllers by targeting viral components for degradation.Keywords
This publication has 52 references indexed in Scilit:
- Global landscape of HIV–human protein complexesNature, 2011
- Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infectionNature, 2011
- Autophagy in immunity and inflammationNature, 2011
- Autophagy and HIVSeminars in Cell & Developmental Biology, 2010
- Human Immunodeficiency Virus-1 Inhibition of Immunoamphisomes in Dendritic Cells Impairs Early Innate and Adaptive Immune ResponsesImmunity, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010
- Autophagy, Immunity, and Microbial AdaptationsCell Host & Microbe, 2009
- Eating the enemy within: autophagy in infectious diseasesCell Death & Differentiation, 2008
- Autophagy fights disease through cellular self-digestionNature, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008